Schaff LR, Mellinghoff IK. Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. JAMA. 2023;329:574–87.

Article  PubMed  Google Scholar 

Mohammed S, Dinesan M, Ajayakumar T. Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study. Reports of Practical Oncology and Radiotherapy. 2022;27:1026.

Article  PubMed  PubMed Central  Google Scholar 

Gatto L, Franceschi E, Tosoni A, Di Nunno V, Tonon C, Lodi R, et al. Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology. Biomedicines. 2022;10:3205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shergalis A, Bankhead A, Luesakul U, Muangsin N, Neamati N. Current challenges and opportunities in treating glioblastomas. Pharmacol Rev. 2018;70:412–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac J Cancer Prev. 2017;18:3.

PubMed  PubMed Central  Google Scholar 

Fink JR, Carr RB, Matsusue E, Iyer RS, Rockhill JK, Haynor DR, et al. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects. J Magn Reson Imaging. 2012;35:56–63.

Article  PubMed  Google Scholar 

Kumar M, Nanga RPR, Chawla S. Editorial: Structural, Metabolic, and Physiologic MR Imaging to Study Glioblastomas. Front Neurol. 2022;13:887027.

Article  PubMed  PubMed Central  Google Scholar 

Chawla S, Bukhari S, Afridi OM, Wang S, Yadav SK, Akbari H, et al. Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma. NMR Biomed. 2022;35:e4719.

Article  PubMed  PubMed Central  Google Scholar 

Gonçalves FG, Chawla S, Mohan S. Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma. J Magn Reson Imaging. 2020;52:978.

Article  PubMed  PubMed Central  Google Scholar 

Aabedi AA, Young JS, Chang EF, Berger MS, Hervey-Jumper SL. Involvement of White Matter Language Tracts in Glioma: Clinical Implications, Operative Management, and Functional Recovery After Injury. Front Neurosci. 2022;16:932478.

Article  PubMed  PubMed Central  Google Scholar 

Bonm AV, Ritterbusch R, Throckmorton P, Graber JJ. Clinical Imaging for Diagnostic Challenges in the Management of Gliomas: A Review. J Neuroimaging. 2020;30:139–45.

Article  PubMed  PubMed Central  Google Scholar 

Prager AJ, Martinez N, Beal K, Omuro A, Zhang Z, Young RJ. Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence. AJNR Am J Neuroradiol. 2015;36:877.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deo RC. Machine Learning in Medicine. Circulation. 2015;132:1920.

Article  PubMed  PubMed Central  Google Scholar 

Beig N, Bera K, Tiwari P. Introduction to radiomics and radiogenomics in neuro-oncology: implications and challenges. Neurooncol Adv. 2020;2:iv3.

PubMed  Google Scholar 

Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alzubaidi L, Zhang J, Humaidi AJ, Al-Dujaili A, Duan Y, Al-Shamma O, et al. Review of deep learning: concepts, CNN architectures, challenges, applications, future directions. J Big Data. 2021;8:1–74.

Article  Google Scholar 

Jiang Y, Yang M, Wang S, Li X, Sun Y. Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun. 2020;40:154.

Article  Google Scholar 

Martin P, Holloway L, Metcalfe P, Koh ES, Brighi C. Challenges in Glioblastoma Radiomics and the Path to Clinical Implementation. Cancers (Basel). 2022;14:3897.

Article  PubMed  PubMed Central  Google Scholar 

Chaddad A, Kucharczyk MJ, Daniel P, Sabri S, Jean-Claude BJ, Niazi T, et al. Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation. Front Oncol. 2019;9:374.

Article  PubMed  PubMed Central  Google Scholar 

Lohmann P, Galldiks N, Kocher M, Heinzel A, Filss CP, Stegmayr C, et al. Radiomics in neuro-oncology: Basics, workflow, and applications. Methods. 2021;188:112–21.

Article  CAS  PubMed  Google Scholar 

Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, et al. Glioblastoma multiforme: Exploratory radiogenomic analysis by using quantitative image features. Radiology. 2014;273:168–74.

Article  PubMed  Google Scholar 

Aftab K, Aamir FB, Mallick S, Mubarak F, Pope WB, Mikkelsen T, et al. Radiomics for precision medicine in glioblastoma. J Neurooncol. 2022;156:217–31.

Article  PubMed  Google Scholar 

Fathi Kazerooni A, Bakas S, Saligheh Rad H, Davatzikos C. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review. J Magn Reson Imaging. 2020;52:54–69.

Article  PubMed  Google Scholar 

Jansen RW, van Amstel P, Martens RM, Kooi IE, Wesseling P, de Langen AJ, et al. Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis. Oncotarget. 2018;9:20134–55.

Article  PubMed  PubMed Central  Google Scholar 

Altieri R, Zenga F, Ducati A, Melcarne A, Cofano F, Mammi M, et al. Tumor location and patient age predict biological signatures of high-grade gliomas. Neurosurg Rev. 2018;41:599–604.

Article  PubMed  Google Scholar 

Choi YS, Bae S, Chang JH, Kang SG, Kim SH, Kim J, et al. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics. Neuro Oncol. 2021;23:304.

Article  CAS  PubMed  Google Scholar 

Liu D, Chen J, Hu X, Yang K, Liu Y, Hu G, et al. Imaging-Genomics in Glioblastoma: Combining Molecular and Imaging Signatures. Front Oncol. 2021;11:1.

Google Scholar 

Wei J, Yang G, Hao X, Gu D, Tan Y, Wang X, et al. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication. Eur Radiol. 2019;29:877.

Article  PubMed  Google Scholar 

Korfiatis P, Kline TL, Lachance DH, Parney IF, Buckner JC, Erickson BJ. Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status. J Digit Imaging. 2017;30:622.

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Zeng M, Tong Y, Zhang T, Fu Y, Li H, et al. Automatic Prediction of MGMT Status in Glioblastoma via Deep Learning-Based MR Image Analysis. Biomed Res Int. 2020;2020:9258649.

PubMed  PubMed Central  Google Scholar 

Liu TT, Achrol AS, Mitchell LA, Rodriguez SA, Feroze A, Iv M, et al. Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment. Neuro Oncol. 2017;19:997.

CAS  PubMed  Google Scholar 

Park JE, Kim HS, Park SY, Nam SJ, Chun SM, Jo Y, et al. Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma. Radiology. 2020;294:388–97.

Article  PubMed  Google Scholar 

Heimberger AB, Hlatky R, Suki D, Yang D, Weinberg J, Gilbert M, et al. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res. 2005;11:1462–6.

Article  CAS